(Q44671474)

5 December 2017

Polyene and cytokine treatment of experimental aspergillosis (English)

1 reference

5 December 2017

0 references

Edward Sionov

1

1 reference

PubMed ID

14642306

5 December 2017

Esther Segal

series ordinal

2

1 reference

5 December 2017

1 December 2003

1 reference

FEMS Immunology and Medical Microbiology

5 December 2017

1 reference

5 December 2017

39

1 reference

5 December 2017

3

1 reference

5 December 2017

221-227

1 reference

Therapeutic outcome in invasive aspergillosis

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

21 January 2018

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Invasive aspergillosis in 2002: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Cytokines in candidiasis and aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Treatment of experimental candidosis with amphotericin B-Intralipid admixtures in immunocompromised mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900230-X

7 January 2021

10.1016/S0928-8244(03)00230-X

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14642306